Ignite Creation Date:
2024-05-06 @ 3:07 PM
Last Modification Date:
2024-10-26 @ 1:43 PM
Study NCT ID:
NCT04521153
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2021-04-27
First Post:
2020-08-18
Brief Title:
Camrelizumab Combined With Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma
Sponsor:
Shanghai Zhongshan Hospital
Organization:
Shanghai Zhongshan Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Molecular Targeted Therapy |
| Hepatocellular Carcinoma |
| Immunotherapy |
Keywords:
| Name | View |
|---|---|
| Camrelizumab apatinib mesylate hepatocellular carcinoma | View |